Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
20.93 23.94 40.30 38.97

+8 more quarters

P/S ratio
0.16 0.19 0.20 0.19
P/FCF ratio
13.31 38.15 17.97 18.89
P/Operating CF
20.59 45.65 (28.46) 19.33
P/B ratio
16.87 17.05 31.30 34.67
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.19 0.22 0.22 0.20
EV/EBITDA
15.46 18.58 19.22 17.28
EV/Operating CF
13.19 31.34 16.73 16.48
EV/FCF
15.48 44.52 19.66 19.92
Quick Ratio
0.48 0.48 0.47 0.51
Current Ratio
0.93 0.95 0.92 0.90
Net Debt/EBITDA
6.37 7.26 6.02 11.70
Debt/Assets
13.99% 15.17% 10.11% 10.00%
Debt/Equity
3.62 3.45 3.78 4.38
Asset Turnover
4.22 4.30 4.42 4.47
Operating CF/Net income
3.48 0.82 (4.12) (9.22)
Capex/Depreciation
(0.81) (0.63) (0.29) (0.95)
Interest Coverage
7.96 8.13 10.50 0.24
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
2.52% 2.52% 2.09% 2.09%
Intangible Assets out of Total Assets
0.27 0.28 0.22 0.23
Share Based Compensation of Revenue
0.03% 0.04% 0.08% 0.03%
Graham Net Nets
(0.46) (0.41) (0.34) (0.37)
Graham Number
71.42 73.75 45.11 40.33
Earnings Yield
4.78% 4.18% 2.48% 2.57%
Free Cash Flow Yield
7.51% 2.62% 5.56% 5.29%
Revenue per Share
438.81 402.77 442.45 431.99
Operating CF per Share
13.74 6.88 (11.87) 16.17
Capex per Share
(1.16) (0.85) (0.39) (1.29)
Free Cash Flow per Share
12.58 6.03 (12.26) 14.88
Cash per Share
14.58 11.19 9.03 22.48
Shareholders Equity per Share
16.77 18.43 10.79 9.01
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
16.77 18.43 10.79 9.01
Free Cash Flow
2,430.06 1,173.74 (2,381.49) 2,883.61
Working Capital
(3,861.96) (2,991.38) (4,980.57) (5,581.47)
Capital Expenditures
(224.00) (164.90) (76.32) (249.81)
Net Current Asset Value
(25,231.32) (24,926.24) (22,113.67) (22,603.95)
EV/EBIT
20.90 25.57 26.75 24.30
Capex to Sales
0.00 0.00 0.00 0.00
Price to Operating Income
17.97 21.91 24.45 23.04
Other line items
Average Receivables
25,004.92 24,304.12 25,262.82 24,548.56
Average Payables
52,871.84 50,996.19 52,987.34 52,830.96
Average Inventory
20,584.10 19,487.76 22,293.26 19,745.66
Average Assets
78,881.23 76,422.99 73,707.76 71,845.89
Average Common Equity
2,724.49 2,382.38 1,228.93 1,266.91

Fold the line items

Columns are period end dates